✦ LIBER ✦

A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design

✍ Scribed by Fox, E.; Wynn, D.; Cohan, S.; Rill, D.; McGuire, D.; Markowitz, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steriods for multiple sclerosis and opti

✍ Fabio Brusaferri; Livia Candelise 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 404 KB

High-dose therapy and autologous blood s

✍ J. P. Fermand; P. Ravaud; S. Chevret; V. Leblond; M. Divine; F. Dreyfus; Belange 📂 Article 📅 1996 🏛 AlphaMed Press 🌐 English ⚖ 304 KB

Clinical profile of patients enroled in

✍ Sara MG Brandão; Isolmar T Schettert; Luiz AM César; José E Krieger; Sérgio A De 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Comparison of pathologic and clinical ev

✍ Gerald E. Hanks; John M. Krall; Miljenko V. Pilepich; Sucha O. Asbell; Carlos A. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 612 KB

High-dose intravenous melphalan and auto

✍ Sanchorawala, V; Wright, D G; Seldin, D C; Falk, R H; Finn, K T; Dember, L M; Be 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 161 KB

A randomized clinical trial of high-inte

✍ G. FINAZZI; R. MARCHIOLI; V. BRANCACCIO; P. SCHINCO; F. WISLOFF; J. MUSIAL; F. B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB